Celladon Ditches Investor Suit Over Mydicar Trial Claims
A California federal judge has tossed a proposed class action targeting pharmaceutical maker Celladon Corp. and two executives for allegedly misleading shareholders about the success of a heart therapy drug prior...To view the full article, register now.
Already a subscriber? Click here to view full article